Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0274969
Abstract: This study evaluated effectiveness and safety of apixaban versus warfarin among venous thromboembolism patients at high-risk of bleeding (defined as having at least one of the following bleeding risk factors: ≥75 years; used antiplatelet, NSAIDs,… read more here.
Keywords: patients high; venous thromboembolism; risk; thromboembolism patients ... See more keywords